Fjarde Ap-fonden’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Buy
68,019
+480
+0.7% +$203K 0.13% 153
2026
Q1
$32M Buy
67,539
+25,070
+59% +$12.6M 0.17% 110
2025
Q4
$19.8M Sell
42,469
-3,300
-7% -$1.53M 0.17% 121
2025
Q3
$19.5M Buy
45,769
+5,600
+14% +$2.17M 0.17% 126
2025
Q2
$15.4M Buy
40,169
+13,300
+49% +$4.79M 0.14% 149
2025
Q1
$9.29M Sell
26,869
-11,000
-29% -$3.54M 0.11% 181
2024
Q4
$11.4M Buy
37,869
+1,600
+4% +$559K 0.11% 169
2024
Q3
$14.7M Buy
+36,269
New +$13.3M 0.15% 139
2024
Q1
$10.9M Buy
32,769
+1,300
+4% +$397K 0.12% 179
2023
Q4
$8.52M Sell
31,469
-6,259
-17% -$1.55M 0.11% 203
2023
Q3
$9.28M Buy
37,728
+700
+2% +$192K 0.12% 172
2023
Q2
$11.2M Sell
37,028
-1,400
-4% -$389K 0.14% 158
2023
Q1
$10.1M Sell
38,428
-13,650
-26% -$3.47M 0.14% 170
2022
Q4
$12.5M Sell
52,078
-7,400
-12% -$1.66M 0.18% 137
2022
Q3
$10M Hold
59,478
0.13% 164
2022
Q2
$10M Sell
59,478
-8,000
-12% -$1.72M 0.13% 164
2022
Q1
$16.9M Sell
67,478
-7,347
-10% -$1.84M 0.17% 119
2021
Q4
$19.2M Sell
74,825
-5,463
-7% -$1.34M 0.17% 115
2021
Q3
$19.5M Sell
80,288
-4,400
-5% -$1.08M 0.18% 112
2021
Q2
$17.5M Buy
84,688
+1,500
+2% +$306K 0.16% 129
2021
Q1
$15.7M Buy
83,188
+1,400
+2% +$247K 0.14% 143
2020
Q4
$13.5M Sell
81,788
-1,200
-1% -$175K 0.13% 151
2020
Q3
$10.3M Buy
82,988
+1,200
+1% +$149K 0.11% 171
2020
Q2
$7.94M Buy
81,788
+4,356
+6% +$453K 0.1% 206
2020
Q1
$6.96M Sell
77,432
-4,500
-5% -$583K 0.11% 176
2019
Q4
$12.1M Buy
81,932
+3,300
+4% +$443K 0.15% 148
2019
Q3
$9.47M Sell
78,632
-1,134
-1% -$147K 0.12% 191
2019
Q2
$10.8M Sell
79,766
-3,400
-4% -$430K 0.14% 168
2019
Q1
$10.8M Buy
83,166
+15,764
+23% +$2.12M 0.14% 157
2018
Q4
$8.39M Sell
67,402
-7,800
-10% -$1.05M 0.14% 149
2018
Q3
$10.5M Sell
75,202
-4,220
-5% -$525K 0.15% 142
2018
Q2
$8.15M Sell
79,422
-2,290
-3% -$232K 0.12% 186
2018
Q1
$7.93M Sell
81,712
-1,015
-1% -$98.5K 0.12% 192
2017
Q4
$7.27M Buy
82,727
+10,310
+14% +$828K 0.11% 205
2017
Q3
$5.76M Buy
72,417
+1,309
+2% +$105K 0.11% 204
2017
Q2
$6.2M Buy
71,108
+9,443
+15% +$799K 0.13% 182
2017
Q1
$5.49M Sell
61,665
-4,827
-7% -$402K 0.13% 175
2016
Q4
$4.92M Sell
66,492
-9,483
-12% -$710K 0.12% 202
2016
Q3
$5.75M Buy
75,975
+498
+0.7% +$38.1K 0.13% 189
2016
Q2
$5.81M Sell
75,477
-812
-1% -$64.1K 0.13% 175
2016
Q1
$5.95M Buy
76,289
+8,520
+13% +$595K 0.14% 166
2015
Q4
$4.58M Buy
67,769
+667
+1% +$46.5K 0.12% 186
2015
Q3
$5.19M Sell
67,102
-7,398
-10% -$655K 0.14% 162
2015
Q2
$6.76M Buy
74,500
+7,178
+11% +$575K 0.16% 141
2015
Q1
$5.07M Sell
67,322
-26,938
-29% -$1.93M 0.12% 205
2014
Q4
$6.92M Hold
94,260
0.15% 157
2014
Q3
$6.65M Sell
94,260
-10,008
-10% -$661K 0.14% 163
2014
Q2
$5.88M Sell
104,268
-5,514
-5% -$291K 0.12% 200
2014
Q1
$5.76M Buy
109,782
+4,141
+4% +$206K 0.11% 200
2013
Q4
$5.04M Buy
105,641
+10,723
+11% +$496K 0.11% 211
2013
Q3
$4.06M Sell
94,918
-8,280
-8% -$324K 0.09% 275
2013
Q2
$3.72M Buy
+103,198
New +$3.99M 0.08% 306

Other funds holding HCA

Fjarde Ap-fonden's HCA Position: Q2 2026 in Review

Fjarde Ap-fonden increased its HCA Healthcare (HCA) stake by 0.71% in Q2 2026, buying an estimated $203K and bringing the position to 68,019 shares worth $26.5M. The position accounts for 0.13% of the portfolio, ranked #153.

Fjarde Ap-fonden first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $32M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Fjarde Ap-fonden held 68,019 shares of HCA Healthcare worth $26.5M as of Q2 2026.
  • Fjarde Ap-fonden bought 480 HCA Healthcare shares in Q2 2026, an estimated $203K.
  • HCA Healthcare made up 0.13% of Fjarde Ap-fonden's portfolio in Q2 2026, its #153 holding.
  • Fjarde Ap-fonden first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Fjarde Ap-fonden's HCA Healthcare position peaked at $32M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.